Molecular Diagnosis and Genomic Insights in Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 43
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to a Special Issue named “Molecular Diagnosis and Genomic Insights in Cancer”. Historically, cancer diagnosis relied heavily on traditional histopathology (microscopic examination of tissue morphology). The field evolved significantly with the advent of molecular techniques. The identification of proto-oncogenes and tumor suppressor genes marked landmark events in cancer research, fundamentally changing how the disease is understood, diagnosed, and treated.
This Special Issue aims to study the transformative impact of advanced genomic technologies on contemporary oncology, moving beyond traditional histopathological classifications to embrace a more precise, molecularly driven approach to patient care.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Key mechanisms of oncogenes/tumor suppressor genes in cancer biology;
- Important progress of gene therapy or cell-based therapy in the cancer field;
- Advancement of molecular pathology roles in cancer diagnosis;
- Molecular research correlation with gene therapy and personalized medicine therapy for various types of cancers.
I look forward to receiving your contributions.
Dr. Jingjing Hu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncogenes
- gene therapy
- next-generation sequencing (NGS)
- targeted therapy
- personalized medicine
- cancer diagnosis
- cancer therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
